Free Trial

Proto Labs (NYSE:PRLB) Share Price Passes Above 200 Day Moving Average - Should You Sell?

Proto Labs logo with Industrial Products background

Proto Labs, Inc. (NYSE:PRLB - Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $34.26 and traded as high as $41.53. Proto Labs shares last traded at $41.38, with a volume of 169,867 shares trading hands.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on PRLB shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Proto Labs in a research note on Thursday, January 16th. Cantor Fitzgerald reissued an "overweight" rating and issued a $40.00 target price on shares of Proto Labs in a research note on Monday, November 4th. Finally, Craig Hallum upped their price target on Proto Labs from $30.00 to $36.00 and gave the company a "hold" rating in a research note on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $40.33.

Read Our Latest Research Report on PRLB

Proto Labs Stock Down 0.8 %

The company has a market capitalization of $1.02 billion, a P/E ratio of 44.34 and a beta of 1.45. The business has a fifty day moving average price of $40.51 and a 200 day moving average price of $34.43.

Proto Labs (NYSE:PRLB - Get Free Report) last released its earnings results on Friday, November 1st. The industrial products company reported $0.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.32 by $0.15. The business had revenue of $125.60 million for the quarter, compared to the consensus estimate of $121.38 million. Proto Labs had a return on equity of 3.49% and a net margin of 4.76%. Proto Labs's quarterly revenue was down 3.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.31 earnings per share. As a group, equities analysts forecast that Proto Labs, Inc. will post 0.84 earnings per share for the current year.

Institutional Trading of Proto Labs

Institutional investors and hedge funds have recently bought and sold shares of the business. KBC Group NV lifted its holdings in Proto Labs by 69.3% during the 3rd quarter. KBC Group NV now owns 1,541 shares of the industrial products company's stock valued at $45,000 after purchasing an additional 631 shares during the last quarter. Modus Advisors LLC bought a new stake in shares of Proto Labs during the 4th quarter worth about $87,000. Point72 Asia Singapore Pte. Ltd. grew its stake in Proto Labs by 40.6% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,108 shares of the industrial products company's stock valued at $121,000 after buying an additional 1,186 shares during the last quarter. Meeder Asset Management Inc. raised its holdings in Proto Labs by 72.3% in the 3rd quarter. Meeder Asset Management Inc. now owns 4,465 shares of the industrial products company's stock valued at $131,000 after acquiring an additional 1,873 shares during the period. Finally, Paloma Partners Management Co acquired a new position in shares of Proto Labs in the third quarter valued at approximately $201,000. Institutional investors own 84.54% of the company's stock.

Proto Labs Company Profile

(Get Free Report)

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.

Featured Stories

Should You Invest $1,000 in Proto Labs Right Now?

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines